Cargando…

Impact of antiviral treatment on long-term prognosis in non-immunocompromised patients with CMV reactivation

BACKGROUND: Reactivation of human cytomegalovirus (CMV) occurs in non-immunocompromised patients with or without specific organ involvement, but it is still unknown whether it has a clinical implication on long-term prognosis or not. METHODS: A retrospective cohort study evaluating non-immunocomprom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Ga Eun, Ki, Hyun Kyun, Ko, Jae-Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094573/ https://www.ncbi.nlm.nih.gov/pubmed/33947335 http://dx.doi.org/10.1186/s12879-021-06098-4

Ejemplares similares

Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients
por: Huntjens, Daan W., et al.
Publicado: (2023)

CMV Pancreatitis in an Immunocompromised Patient
por: Ahmad, Jaffer, et al.
Publicado: (2021)

Clinical Benefits of Piperacillin/Tazobactam versus a Combination of Ceftriaxone and Clindamycin in the Treatment of Early, Non-Ventilator, Hospital-Acquired Pneumonia in a Community-Based Hospital
por: Park, Ga Eun, et al.
Publicado: (2020)

CMV reactivation initiates long-term expansion and differentiation of the NK cell repertoire
por: Hassan, Norfarazieda, et al.
Publicado: (2022)

Successful Use of Heterologous CMV-Reactive T Lymphocyte to Treat Severe Refractory Cytomegalovirus (CMV) Infection in a Liver Transplanted Patient: Correlation of the Host Antiviral Immune Reconstitution with CMV Viral Load and CMV miRNome
por: Miele, Monica, et al.
Publicado: (2021)

S291: LONG-TERM SAFETY AND EFFICACY OF CMV/EBV-SPECIFIC T CELLS FOR CMV AND EBV CO-REACTIVATION AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION
por: Xuying, Pei, et al.
Publicado: (2023)

Atypical presentations of MERS-CoV infection in immunocompromised hosts
por: Kim, Si-Ho, et al.
Publicado: (2017)

Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections
por: Pinninti, Swetha, et al.
Publicado: (2023)

604 Risk Factors for Cytomegalovirus (CMV) Reactivation in CMV-seropositive Liver Transplant Patients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients
por: Lee, Hyeyoung, et al.
Publicado: (2017)

CMV Serostatus of Donor-Recipient Pairs Influences the Risk of CMV Infection/Reactivation in HSCT Patients
por: Jaskula, Emilia, et al.
Publicado: (2012)

IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients
por: Sadeghi, Mahmoud, et al.
Publicado: (2016)

Donor CMV Reactivation as a Novel Risk Factor for CMV Replication in Seropositive Liver Transplant Recipients
por: Limaye, Ajit P., et al.
Publicado: (2020)

CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality
por: Eberhardt, Kirsten Alexandra, et al.
Publicado: (2023)

First case of concomitant cytomegalovirus (CMV) viremia in non‐immunocompromised COVID‐19 patient and ICU management strategy in Qatar with literature review
por: Iqbal, Phool, et al.
Publicado: (2022)

Long-term CMV monitoring and chronic rejection in renal transplant recipients
por: Ishikawa, Shoko, et al.
Publicado: (2023)

Targeting CMV Reactivation to Optimize Care for Critically Ill COVID-19 Patients: A Review on the Therapeutic Potential of Antiviral Treatment
por: Schinas, Georgios, et al.
Publicado: (2023)

13. CMV Reactivation in refractory ANCA-associated vasculitis
por: Hassan, Neelam, et al.
Publicado: (2019)

A Systematic Review and Meta-analysis of Optimized CMV Preemptive Therapy and Antiviral Prophylaxis for CMV Disease Prevention in CMV High-Risk (D+R-) Kidney Transplant Recipients
por: Kumar, Lakshin, et al.
Publicado: (2023)

Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection
por: Gordon, Claire L., et al.
Publicado: (2017)

Performance Evaluation of the Real-Q Cytomegalovirus (CMV) Quantification Kit Using Two Real-Time PCR Systems for Quantifying CMV DNA in Whole Blood
por: Park, Jong Eun, et al.
Publicado: (2016)

Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients
por: Kim, Jong Man, et al.
Publicado: (2015)

The immunological footprint of CMV in HIV-1 patients stable on long-term ART
por: Affandi, Jacquita S., et al.
Publicado: (2015)

Clinical Implications of the CMV-Specific T-Cell Response and Local or Systemic CMV Viral Replication in Patients With Moderate to Severe Ulcerative Colitis
por: Jung, Kyung Hwa, et al.
Publicado: (2019)

Cytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel Disease
por: Nowacki, Tobias M., et al.
Publicado: (2012)

Tissue-specific control of latent CMV reactivation by regulatory T cells
por: Almanan, Maha, et al.
Publicado: (2017)

CMV reactivation caused by methylprednisolone therapy for ARDS after esophagectomy
por: Sato, Yusuke, et al.
Publicado: (2012)

IgA Vasculitis Complicated by Both CMV Reactivation and Tuberculosis
por: Mizerska-Wasiak, Małgorzata, et al.
Publicado: (2021)

Cytomegalovirus Pneumonia: High-Resolution CT Findings in Ten Non-AIDS Immunocompromised Patients
por: Moon, Jeung Hee, et al.
Publicado: (2000)

Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma
por: Borges, Vítor, et al.
Publicado: (2021)

Novel Antiviral Agents for Respiratory Viral Infection in Immunocompromised Adults
por: Hawkinson, Dana, et al.
Publicado: (2013)

Guillain-Barré Syndrome due to CMV Reactivation after Cardiac Transplantation
por: Steger, Christina Maria, et al.
Publicado: (2012)

Detection of cytomegalovirus (CMV) by digital PCR in stool samples for the non-invasive diagnosis of CMV gastroenteritis
por: Gu, Jia, et al.
Publicado: (2022)

Long-term Shedding of Influenza A Virus in Stool of Immunocompromised Child
por: Pinsky, Benjamin A., et al.
Publicado: (2010)

Microevolution of Campylobacter jejuni during long-term infection in an immunocompromised host
por: Barker, Clare R., et al.
Publicado: (2020)

Reactivation of Occult Hepatitis B Virus Infection During Long-Term Entecavir Antiviral Therapy
por: Yuan, Chunyan, et al.
Publicado: (2022)

A Case of CMV Disease of the Jejunum in a Patient with Non-Hodgkin’s Lymphoma
por: Han, Ki Ju, et al.
Publicado: (1998)

Long-COVID in immunocompromised children
por: Kuczborska, Karolina, et al.
Publicado: (2022)

1551. The Impact of Recurrent CMV Disease on Long-Term Survival in Solid Organ Transplant Recipients
por: Gardiner, Bradley, et al.
Publicado: (2018)

How Do Donor-Recipient CMV Serostatus and Post-Hematopoietic Stem Cell Transplantation CMV Reactivation Affect Outcomes in Acute Leukemia Patients?
por: Vaezi, Mohammad, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_00ndj055qq9n4pn0fm3m6c7dmt